[FGV] YoY Cumulative Quarter Result on 31-Dec-2018 [#4]

Stock
[FGV] FGV HOLDINGS BERHAD
Announcement Date
28-Feb-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
31-Dec-2018 [#4]
Profit Trend
QoQ- -23.97%
YoY- -851.39%
Quarter Report
Latest QR
Upcoming QR
FGV's Result
FGV's Financial Summary
View:
Show?
Cumulative Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 19,575,323 14,075,712 13,259,012 13,467,261 16,974,713 17,241,275 15,669,741 3.77%
PBT 1,696,574 337,195 -356,657 -1,041,554 411,534 242,537 359,934 29.45%
Tax -520,996 -198,417 -14,446 -100,569 -203,488 -176,078 -47,928 48.78%
NP 1,175,578 138,778 -371,103 -1,142,123 208,046 66,459 312,006 24.71%
-
NP to SH 1,167,874 150,020 -242,191 -1,079,952 143,727 31,466 117,123 46.65%
-
Tax Rate 30.71% 58.84% - - 49.45% 72.60% 13.32% -
Total Cost 18,399,745 13,936,934 13,630,115 14,609,384 16,766,667 17,174,816 15,357,735 3.05%
-
Net Worth 5,435,746 4,268,337 4,195,374 4,450,745 5,618,153 5,800,561 6,457,228 -2.82%
Dividend
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Div 2,918 1,094 72,963 - 182,407 - 145,926 -47.87%
Div Payout % 0.25% 0.73% 0.00% - 126.91% - 124.59% -
Equity
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Net Worth 5,435,746 4,268,337 4,195,374 4,450,745 5,618,153 5,800,561 6,457,228 -2.82%
NOSH 3,648,152 3,648,152 3,648,152 3,648,152 3,648,152 3,648,152 3,648,152 0.00%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin 6.01% 0.99% -2.80% -8.48% 1.23% 0.39% 1.99% -
ROE 21.49% 3.51% -5.77% -24.26% 2.56% 0.54% 1.81% -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
RPS 536.58 385.83 363.44 369.15 465.30 472.60 429.53 3.77%
EPS 32.01 4.10 -6.60 -29.60 3.90 0.90 3.20 46.73%
DPS 0.08 0.03 2.00 0.00 5.00 0.00 4.00 -47.86%
NAPS 1.49 1.17 1.15 1.22 1.54 1.59 1.77 -2.82%
Adjusted Per Share Value based on latest NOSH - 3,648,152
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
RPS 536.58 385.83 363.44 369.15 465.30 472.60 429.53 3.77%
EPS 32.01 4.10 -6.60 -29.60 3.90 0.90 3.20 46.73%
DPS 0.08 0.03 2.00 0.00 5.00 0.00 4.00 -47.86%
NAPS 1.49 1.17 1.15 1.22 1.54 1.59 1.77 -2.82%
Price Multiplier on Financial Quarter End Date
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Date 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 -
Price 1.48 1.28 1.52 0.715 1.69 1.55 1.71 -
P/RPS 0.28 0.33 0.42 0.19 0.36 0.33 0.40 -5.76%
P/EPS 4.62 31.13 -22.90 -2.42 42.90 179.71 53.26 -33.44%
EY 21.63 3.21 -4.37 -41.40 2.33 0.56 1.88 50.19%
DY 0.05 0.02 1.32 0.00 2.96 0.00 2.34 -47.29%
P/NAPS 0.99 1.09 1.32 0.59 1.10 0.97 0.97 0.34%
Price Multiplier on Announcement Date
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Date 28/02/22 26/02/21 28/02/20 28/02/19 23/02/18 28/02/17 29/02/16 -
Price 2.04 1.33 1.15 1.12 1.99 1.88 1.53 -
P/RPS 0.38 0.34 0.32 0.30 0.43 0.40 0.36 0.90%
P/EPS 6.37 32.34 -17.32 -3.78 50.51 217.97 47.66 -28.47%
EY 15.69 3.09 -5.77 -26.43 1.98 0.46 2.10 39.77%
DY 0.04 0.02 1.74 0.00 2.51 0.00 2.61 -50.12%
P/NAPS 1.37 1.14 1.00 0.92 1.29 1.18 0.86 8.06%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment